{"id":"https://openalex.org/W4361885370","doi":"https://doi.org/10.1158/1078-0432.22461569","title":"Supplementary Table 2 from Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC","display_name":"Supplementary Table 2 from Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361885370","doi":"https://doi.org/10.1158/1078-0432.22461569"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22461569","doi":"https://doi.org/10.1158/1078-0432.22461569","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22461569","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.22461569","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058793243","display_name":"Hideho Okada","orcid":"https://orcid.org/0000-0003-0076-9920","observed_orcids":["https://orcid.org/0000-0003-0076-9920"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hideho Okada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026029856","display_name":"Lisa Helene Butterfield","orcid":"https://orcid.org/0000-0002-3439-9844","observed_orcids":["https://orcid.org/0000-0002-3439-9844"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa H. Butterfield","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002782232","display_name":"Ronald L. Hamilton","orcid":"https://orcid.org/0000-0002-6802-1102","observed_orcids":["https://orcid.org/0000-0002-6802-1102"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald L. Hamilton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062850215","display_name":"Aki Hoji","orcid":"https://orcid.org/0000-0001-7093-3437","observed_orcids":["https://orcid.org/0000-0001-7093-3437"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aki Hoji","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061817630","display_name":"Masashi Sakaki","orcid":"https://orcid.org/0000-0002-4431-3493","observed_orcids":["https://orcid.org/0000-0002-4431-3493"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masashi Sakaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068121760","display_name":"Brian J. Ahn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian J. Ahn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022169733","display_name":"Gary Kohanbash","orcid":"https://orcid.org/0000-0002-3953-8022","observed_orcids":["https://orcid.org/0000-0002-3953-8022"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary Kohanbash","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091053515","display_name":"Jan Drappatz","orcid":"https://orcid.org/0000-0001-8187-7119","observed_orcids":["https://orcid.org/0000-0001-8187-7119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan Drappatz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057531524","display_name":"Johnathan A. Engh","orcid":"https://orcid.org/0000-0003-4270-309X","observed_orcids":["https://orcid.org/0000-0003-4270-309X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johnathan Engh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009622274","display_name":"Nduka Amankulor","orcid":"https://orcid.org/0000-0001-6217-1954","observed_orcids":["https://orcid.org/0000-0001-6217-1954"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nduka Amankulor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025785938","display_name":"Mark O. Lively","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark O. Lively","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053414244","display_name":"Michael David Chan","orcid":"https://orcid.org/0000-0002-5278-6709","observed_orcids":["https://orcid.org/0000-0002-5278-6709"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael D. Chan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091736003","display_name":"Andres \u039c. Salazar","orcid":"https://orcid.org/0000-0003-1723-691X","observed_orcids":["https://orcid.org/0000-0003-1723-691X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andres M. Salazar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103415116","display_name":"Edward G. Shaw","orcid":"https://orcid.org/0009-0004-2914-0119","observed_orcids":["https://orcid.org/0009-0004-2914-0119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward G. Shaw","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111991039","display_name":"Douglas M. Potter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas M. Potter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5014264452","display_name":"Frank Scott Lieberman","orcid":"https://orcid.org/0000-0003-2577-3336","observed_orcids":["https://orcid.org/0000-0003-2577-3336"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank S. Lieberman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6176999807357788,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6176999807357788,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.3743000030517578,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/low-grade-glioma","display_name":"low-grade glioma","score":0.8659999966621399},{"id":"https://openalex.org/keywords/peptide-vaccine","display_name":"peptide vaccine","score":0.8100000023841858},{"id":"https://openalex.org/keywords/poly-iclc","display_name":"poly-ICLC","score":0.972000002861023},{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.6990000009536743},{"id":"https://openalex.org/keywords/cd8-t-cell-responses","display_name":"CD8+ T cell responses","score":0.906000018119812},{"id":"https://openalex.org/keywords/elispot","display_name":"ELISPOT","score":0.8970000147819519},{"id":"https://openalex.org/keywords/pediatric-glioma","display_name":"pediatric glioma","score":0.8769999742507935},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5156868696212769},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.4200630784034729},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.41784876585006714},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3737006187438965},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36938151717185974},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28659531474113464},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.26791253685951233},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26288047432899475},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07768741250038147}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22461569","doi":"https://doi.org/10.1158/1078-0432.22461569","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22461569","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22461569.v1","doi":"https://doi.org/10.1158/1078-0432.22461569.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22461569.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22461569","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_2_from_Induction_of_Robust_Type-I_CD8_sup_sup_T-cell_Responses_in_WHO_Grade_2_Low-Grade_Glioma_Patients_Receiving_Peptide-Based_Vaccines_in_Combination_with_Poly-ICLC/22461569","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22461569","doi":"https://doi.org/10.1158/1078-0432.22461569","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22461569","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2140738072","https://openalex.org/W2333324411","https://openalex.org/W4361958494","https://openalex.org/W4234403201","https://openalex.org/W2989587494","https://openalex.org/W2796417814","https://openalex.org/W2990939179","https://openalex.org/W2137405984","https://openalex.org/W1982217527","https://openalex.org/W4416627481"],"abstract_inverted_index":{"Supplementary":[0],"Table":[1],"2.":[2],"Comparison":[3],"of":[4],"ELISPOT":[5],"responses":[6],"between":[7],"the":[8],"current":[9],"study":[10,14],"and":[11],"our":[12],"recent":[13],"in":[15],"pediatric":[16],"glioma":[17],"patients":[18]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}